Amuza

Executive Summary

Amuza Inc. is a San Diego-based neuroscience research tools company specializing in advanced laboratory instruments and solutions for studying neurological and psychiatric disorders. Founded in 2015, the company provides researchers with cutting-edge technologies including wireless optogenetics, HPLC-ECD systems for neurotransmitter analysis, and behavioral neuroscience tools. Amuza operates as a partner to academic and research institutions, offering customized equipment, support, and guidance throughout the research process. By enabling precise and reliable research outcomes, the company plays a critical role in advancing understanding of complex brain disorders. With a focus on innovation and customization, Amuza has established a niche in the neuroscience tools market, serving a global customer base of laboratories seeking high-quality, reproducible results. The company's products are essential for preclinical studies in areas such as Parkinson's disease, depression, and addiction, positioning it as a key enabler of neuroscience breakthroughs.

Upcoming Catalysts (preview)

• Q3 2026Launch of next-generation wireless optogenetics system with improved battery life and data transmission70% success
• H2 2026Strategic partnership with a major pharmaceutical company for co-development of behavioral neuroscience assays50% success
• Q4 2026Expansion into European and Asian markets through new distribution agreements60% success